Healthcare >> Analyst Interviews >> February 23, 2009

INVESTING IN SPECIALTY PHARMA COMPANIES – LOUISE CHEN – COLLINS STEWART LLC

LOUISE CHEN has been at Collins Stewart for the past two years. Prior to joining Collins Stewart, she was an Analyst at Morgan Stanley, where she also covered specialty pharmaceuticals. She previously worked at Dr. Reddys Laboratories in business development. Ms. Chen started her investment banking career at DLJ Financial in mergers and acquisitions, and she subsequently went to TD Capital to handle private equity. Ms. Chen has an MBA from Harvard University and an undergraduate degree from Brown University. Profile
TWST: As you look back at 2008 in the specialty pharma space, what were the

highlights?

Ms. Chen: When you look at 2008, you saw that spec pharma, the space measured by

the DRG and the BTK,